Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on June 3, 2025

Tower Semiconductor to Present at IMS 2025 Highlighting Recent Innovations in RF Foundry Technology
Presenting a joint white paper with pSemi nominated for Best Industry Paper Award highlighting next-generation RF switch technology MIGDAL HAEMEK, Israel, June 3, 2025 – Tower Semiconductor (NASDAQ/TASE: TSEM), a leading foundry of high-value analog …

CHEOPS TECHNOLOGY, leader Français du cloud souverain et de la confidentialité ouvre une nouvelle agence à Aix-en-Provence
COMMUNIQUÉ DE PRESSE Canéjan et Aix-en-Provence, le mardi 3 juin 2025 CHEOPS TECHNOLOGY, LEADER FRANÇAIS DU CLOUD SOUVERAIN ET DE LA CONFIDENTIALITÉ DE LA DATA OUVRE UNE NOUVELLE AGENCE À AIX-EN-PROVENCE CHEOPS TECHNOLOGY annonce aujourd’hui l’ouverture …

MoonFox Data Releases New Report: Instant Retail Becomes the Next Battleground as JD.com and Meituan Intensify Food Delivery Competition in China
Shenzhen, June 03, 2025 (GLOBE NEWSWIRE) -- [Shenzhen, China] – [June 3, 2025] – MoonFox Data, a leading provider of market intelligence and data analytics, today released its latest report, “Instant Retail Remains a Long-Term Battle, and the Food Delivery …

Aurora Mobile’s Subsidiaries EngageLab and GPTBots.ai Achieve SOC 2 Type II Certification, Setting a New Benchmark for Global Data Security
SHENZHEN, China, June 03, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its flagship platforms, …

HashiCorp Expands Unified Lifecycle Management for Hybrid Cloud Operations
LONDON, June 03, 2025 (GLOBE NEWSWIRE) -- Today at HashiDays London, its first international user conference as an IBM company, HashiCorp unveiled the vision for partnering with IBM to shape the future of hybrid cloud automation. Despite widespread …

Oculis to Participate in Upcoming June Investor Conferences
ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs …

Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 Inhibitor for Rare Genetic Skin Diseases
Financing co-led by new investor BRM Group and existing investor Pontifax Lead program KM023 is a first-in-class oral TRPV3 inhibitor entering clinical development for the treatment of three rare genetic skin diseases; Olmsted syndrome, severe keratoderma …

CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
Lehi, June 03, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 3rd, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform that will use the body’s immune system to fight cancer, today announced that two of its lead …

AI data-fabric Treefera secures $30 million in Series B funding to accelerate global expansion and meet demand for supply chain transparency
LONDON, UK, June 03, 2025 (GLOBE NEWSWIRE) -- Treefera, the leading AI-enabled data fabric for supply chain resilience, today announced that it has raised $30 million in Series B funding to drive product development and expansion across North America, APAC …

Life360 Announces Pricing of Upsized Convertible Senior Notes Offering
SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Life360, Inc. (“Life360” or the “Company”) (NASDAQ: LIF, ASX: 360), today announced the pricing of its offering of $275.0 million aggregate principal amount of 0.00% convertible senior notes due 2030 (the “ …

argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
June 3, 2025 Amsterdam, the Netherlands – argenx (Euronext …

Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare diseases Under regulatory review in the US, the EU, and China in immune thrombocytopenia Paris, June 3, 2025. The US …

Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de la drépanocytose
Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de la drépanocytose Quatrième désignation de médicament orphelin pour le rilzabrutinib dans les maladies rares En cours d’examen réglementaire aux États-Unis, …

Addex Convenes Annual General Meeting 2025
Geneva, Switzerland, June 3, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that …

The Crisis of Care: Caily Confronts Caregiver Burnout with Launch of Comprehensive Digital Platform in Summer 2025
Denver, CO, June 02, 2025 (GLOBE NEWSWIRE) -- As caregiver burnout reaches unprecedented levels across the United States, a new health tech startup, Caily, is stepping forward to address what experts are calling a growing public health emergency. The …